Journal•ISSN: 2352-3018
The Lancet HIV
Elsevier BV
About: The Lancet HIV is an academic journal published by Elsevier BV. The journal publishes majorly in the area(s): Medicine & Population. It has an ISSN identifier of 2352-3018. Over the lifetime, 1242 publications have been published receiving 31458 citations.
Topics: Medicine, Population, Human immunodeficiency virus (HIV), Acquired immunodeficiency syndrome (AIDS), Viral load
Papers
More filters
••
TL;DR: Even in the late ART era, survival during the first 3 years of ART continues to improve, which probably reflects transition to less toxic antiretroviral drugs, improved adherence, prophylactic measures, and management of comorbidity.
762 citations
••
TL;DR: This report provides national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015.
522 citations
••
TL;DR: Panobinostat effectively disrupts HIV latency in vivo and is a promising candidate for future combination clinical trials aimed at HIV eradication, however, panobinostats did not reduce the number of latently infected cells and this approach may need to be combined with others to significantly affect the latent HIV reservoir.
516 citations
••
TL;DR: The first single-centre experience of COVID-19 in patients infected with HIV-1 is described, to the authors' knowledge, including clinical characteristics, antiviral and antiretroviral treatment, and outcomes.
358 citations
••
TL;DR: On-demand oral PrEP is highly effective at preventing HIV infection among high-risk men who have sex with men and therefore represents an alternative to daily PrEP, expanding choices for HIV prevention.
348 citations